Blow For EU Tecfidera Rivals As Biogen Triumphs In Legal Battle
Follows October 2022 Opinion From Advocate General Of CJEU In Favor Of Biogen
Developers of generic dimethyl fumarate have received a setback after a CJEU ruling in Biogen’s favor gave Tecfidera EU regulatory marketing protection until at least February 2024.